In this video, I outline how a new long-lasting injectable HIV drug works against common Anti Retroviral Therapy drug-resistant mutations, and how well it suppresses viral replication in a humanized mouse model.

This is a summary of the scientific research paper: A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model.

by: Stephen R Yant, Andrew Mulato, Derek Hansen, Winston C Tse, Anita Niedziela-Majka, Jennifer R Zhang, George J Stepan, Debi Jin, Melanie H Wong, Jill M Perreira, Eric Singer, Giuseppe A Papalia, Eric Y Hu, Jim Zheng, Bing Lu, Scott D Schroeder, Kevin Chou, Shekeba Ahmadyar, Albert Liclican, Helen Yu, Nikolai Novikov, Eric Paoli, Daniel Gonik, Renee R Ram, Magdeleine Hung, William M McDougall, Abraham L Brass, Wesley I Sundquist, Tomas Cihlar, John O Link

This is a link to where you can find a copy of the article for yourself to read: https://pubmed.ncbi.nlm.nih.gov/31501...

Sections:
0:00 Introduction
6:19 Importance
7:00 Design of a broadly reactive Lyme disease vaccine.
7:33 Results
11:35 Summary
12:20 Significance
12:58 Future Directions

Twitter:   / invexdis  

Show your support with a coffee :)
https://www.buymeacoffee.com/InvExDis